Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin

Abstract Antibody‐mediated graft rejection caused by donor‐specific antibodies (DSA‐MR) remains a serious problem after heart transplantation (HTx). IgM‐enriched human intravenous immunoglobulin (IGM‐IVIG) consists of 76% IgG, 12% IgM, and 12% IgA and provides a new multifactorial approach for DSA‐M...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Moritz Benjamin Immohr, Payam Akhyari, Hug Aubin, Ralf Westenfeld, Arash Mehdiani, Raphael Romano Bruno, Nihat Firat Sipahi, Sophiko Erbel‐Khurtsidze, Petra Reinecke, Igor Tudorache, Artur Lichtenberg, Udo Boeken
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Oxford University Press 2021-08-01
Edice:	ESC Heart Failure
Témata:	Heart transplantation Antibody mediated rejection Immunoglobulin IgM Donor specific antibody
On-line přístup:	https://doi.org/10.1002/ehf2.13409
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!